An open-label, multicenter phase II trial of sunitinib for patients with chemorefractory metastatic gastric cancer.

被引：2
|
作者：
Moehler, M. H.
Hartmann, J. T.
Lordick, F.
Al-Batran, S.
Reimer, P.
Trarbach, T.
Ebert, M. P.
Daum, S.
Weihrauch, M.
Galle, P. R.
机构：
[1] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany
[2] Christian Albrechts Univ Kiel Klinikum, Kiel, Germany
[3] Klinikum Braunschweig, Med Dept 3, Braunschweig, Germany
[4] Krankenhaus NW Frankfurt, Frankfurt, Germany
[5] Kliniken Essen Sued, Essen, Germany
[6] Univ Duisburg Essen, Dept Med, West German Canc Ctr, Essen, Germany
[7] Tech Univ Munich, Klinikum Rechts Isar, Med Dept 2, D-80290 Munich, Germany
[8] Charite, Berlin, Germany
[9] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14503
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14503
引用
收藏
页数：1
相关论文
共 50 条
  • [21] (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
    Reni, Michele
    Dugnani, Erica
    Cereda, Stefano
    Belli, Carmen
    Balzano, Gianpaolo
    Nicoletti, Roberto
    Liberati, Daniela
    Pasquale, Valentina
    Scavini, Marina
    Maggiora, Paola
    Sordi, Valeria
    Lampasona, Vito
    Ceraulo, Domenica
    Di Terlizzi, Gaetano
    Doglioni, Claudio
    Falconi, Massimo
    Piemonti, Lorenzo
    CLINICAL CANCER RESEARCH, 2016, 22 (05) : 1076 - 1085
  • [22] Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
    Song, Zhengbo
    Lou, Guangyuan
    Wang, Yina
    Yang, Zhiping
    Wang, Wenxian
    Ji, Yongling
    Chen, Shiqing
    Xu, Chunwei
    Hu, Xiao
    Zhang, Yiping
    BMC MEDICINE, 2022, 20 (01)
  • [23] Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial
    Stroehlein, Michael A.
    Lordick, Florian
    Ruettinger, Dominik
    Gruetzner, Klaus-Uwe
    Schemanski, Oliver C.
    Jaeger, Michael
    Lindhofer, Horst
    Hennig, Michael
    Jauch, Karl-Walter
    Peschel, Christian
    Heiss, Markus M.
    ONKOLOGIE, 2011, 34 (03): : 101 - 108
  • [24] Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
    Zhengbo Song
    Guangyuan Lou
    Yina Wang
    Zhiping Yang
    Wenxian Wang
    Yongling Ji
    Shiqing Chen
    Chunwei Xu
    Xiao Hu
    Yiping Zhang
    BMC Medicine, 20
  • [25] Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
    Wirth, Lori J.
    Brose, Marcia S.
    Sherman, Eric J.
    Licitra, Lisa
    Schlumberger, Martin
    Sherman, Steven, I
    Bible, Keith C.
    Robinson, Bruce
    Rodien, Patrice
    Godbert, Yann
    De La Fouchardiere, Christelle
    Newbold, Kate
    Nutting, Christopher
    Misir, Soamnauth
    Xie, Ran
    Almonte, Ana
    Ye, Weifei
    Cabanillas, Maria E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (21) : 2359 - +
  • [26] TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial
    Pfeiffer, Per
    Yilmaz, Mette
    Moller, Soren
    Zitnjak, Daniela
    Krogh, Merete
    Petersen, Lone Norgard
    Poulsen, Laurids Ostergaard
    Winther, Stine Braendegaard
    Thomsen, Karina Gravgaard
    Qvortrup, Camilla
    LANCET ONCOLOGY, 2020, 21 (03): : 412 - 420
  • [27] A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer
    Xu, Jianming
    Bai, Yuxian
    Sun, Huichuan
    Bai, Chunmei
    Jia, Ru
    Li, Yi
    Zhang, Wenjie
    Liu, Lei
    Huang, Cheng
    Guan, Mei
    Zhou, Jinghong
    Su, Weiguo
    CANCER, 2021, 127 (21) : 3975 - 3984
  • [28] Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
    Kroiss, Matthias
    Quinkler, Marcus
    Johanssen, Sarah
    van Erp, Nielka P.
    Lankheet, Nienke
    Poellinger, Alexander
    Laubner, Katharina
    Strasburger, Christian J.
    Hahner, Stefanie
    Mueller, Hans-Helge
    Allolio, Bruno
    Fassnacht, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10): : 3495 - 3503
  • [29] A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis
    Morgan, Timothy
    Asghar, Aliya
    Tayek, John
    Nguyen, Danh
    Fleischman, M. Wayne
    Donovan, John
    Alcorn, Joseph
    Chao, Daniel
    Stolz, Andrew
    JOURNAL OF HEPATOLOGY, 2022, 77 : S142 - S142
  • [30] A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis
    Tayek, John A.
    Stolz, Andrew A.
    Nguyen, Danh, V
    Fleischman, M. Wayne
    Donovan, John A.
    Alcorn, Joseph M.
    Chao, Daniel C-K
    Asghar, Aliya
    Morgan, Timothy R.
    ECLINICALMEDICINE, 2022, 54
12345